Know Cancer

or
forgot password

Outcome Study of Cesium-131 Brachytherapy Following Sub-Lobar Resection for Early Stage NSCLC


N/A
N/A
N/A
Open (Enrolling)
Both
NSCLC, Non Small Cell Lung Cancer

Thank you

Trial Information

Outcome Study of Cesium-131 Brachytherapy Following Sub-Lobar Resection for Early Stage NSCLC


Inclusion Criteria:



1. Patients must have suspicious lung nodule for clinical stage I/recurrent non-small
cell Lung Cancer

2. Mass Tumor size < 7 cm

3. Patient must have a CT scan of the chest with upper abdomen within 90 days prior to
date of pre-registration.

4. Patient must have ECOG/Zubrod performance status 0,1, or 2.

Exclusion Criteria:

1. Patient has already received high dose radiation to the area

2. Cancerous nodule is very close to the esophagus or spinal cord, thereby increasing
the risk of radiation treatment

3. Pregnancy or unwillingness to practice a form of birth control (i.e. abstinence, oral
contraceptives, etc.)

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

Local Recurrence

Outcome Description:

Cancer regrowth in the area where it was surgically removed

Outcome Time Frame:

3 Years

Safety Issue:

No

Principal Investigator

Bhupesh Parashar, M.D.

Investigator Role:

Principal Investigator

Investigator Affiliation:

Weill Medical College of Cornell University

Authority:

United States: Institutional Review Board

Study ID:

Cs131-Lung001

NCT ID:

NCT01237171

Start Date:

November 2010

Completion Date:

May 2014

Related Keywords:

  • NSCLC
  • Non Small Cell Lung Cancer
  • Brachytherapy
  • Lung Brachytherapy
  • NSCLC
  • Sub-lobar resection
  • Carcinoma, Non-Small-Cell Lung
  • Lung Neoplasms

Name

Location

Weill Cornell Medical CollegeNew York, New York  10021